CollPlant Biotechnologies (CLGN) Receivables (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Receivables of $211000.0 for Q4 2025, down 99.86% on a QoQ basis from $150.0 million in Q4 2024, and down 99.86% year-over-year from $150.0 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Receivables (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Receivables history runs 9 years deep, the most recent figure standing at $211000.0 for Q4 2025.
- Quarterly Receivables fell 99.86% year-over-year to $211000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $211000.0 (down 99.86% YoY) and the FY2025 annual result came in at $211000.0, down 99.86% from the prior year.
- Receivables was $211000.0 for Q4 2025 at CollPlant Biotechnologies, down from $150.0 million in the prior quarter.
- Across five years, Receivables topped out at $270.0 billion in Q4 2021 and bottomed at -$463000.0 in Q2 2021.
- A 5-year average of $18.0 billion and a median of $4.0 million in 2023 frame the typical range for Receivables.
- Peak annual rise in Receivables reached 31358763.53% in 2021, while the deepest fall reached 191.19% in 2021.
- CollPlant Biotechnologies' Receivables stood at $270.0 billion in 2021, then tumbled by 100.0% to $8.9 million in 2022, then sank by 54.4% to $4.0 million in 2023, then jumped by 3602.72% to $150.0 million in 2024, then plunged by 99.86% to $211000.0 in 2025.
- Business Quant data shows CLGN's Receivables at $211000.0 in Q4 2025, $150.0 million in Q4 2024, and $5.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 149.96 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 90.00 Mn |
| Sep 30, 2023 | 4.05 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 458,000.00 |
| Dec 31, 2022 | 8.88 Mn |
| Sep 30, 2022 | -56,000.00 |
| Jun 30, 2022 | -161,000.00 |
| Dec 31, 2021 | 270.00 Bn |
| Sep 30, 2021 | -369,000.00 |
| Jun 30, 2021 | -463,000.00 |
| Mar 31, 2021 | 173.97 Mn |
| Dec 31, 2020 | 861,000.00 |
| Sep 30, 2020 | 611,000.00 |
| Jun 30, 2020 | -159,000.00 |
| Mar 31, 2020 | 455,000.00 |
| Dec 31, 2019 | 79.04 Mn |